folic acid has been researched along with Bright Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andres-Hernando, A; Cara-Fuentes, G; Garcia, GE; Johnson, RJ; Lanaspa, M; Leamon, CP; Lu, YJ; Miyazaki, M; Miyazaki-Anzai, S; Roncal-Jiménez, CA; Truong, LD | 1 |
| Lindeman, RD | 1 |
| Duclos, J | 1 |
3 other study(ies) available for folic acid and Bright Disease
| Article | Year |
|---|---|
A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats.
Topics: Aminopterin; Animals; Fibrosis; Folate Receptor 2; Folic Acid; Glomerulonephritis; Inflammation; Macrophages; Methotrexate; Rats | 2021 |
Drug treatment of the chronic idiopathic glomerulopathies.
Topics: Adrenal Cortex Hormones; Alkylating Agents; B-Lymphocytes; Chronic Disease; Dipyridamole; Folic Acid; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Indomethacin; Kidney Diseases; Kidney Glomerulus; Nephrotic Syndrome; Plasmapheresis; Proteinuria; Purines; T-Lymphocytes | 1977 |
[Parenteral iron and folic acid in patients on chronic hemodialysis: requirements, monitoring, and effective use].
Topics: Adult; Aged; Chronic Disease; Female; Ferritins; Folic Acid; Glomerulonephritis; Hematologic Tests; Humans; Infusions, Parenteral; Iron; Male; Middle Aged; Prospective Studies; Renal Dialysis | 1991 |